Price
$0.19
Decreased by -15.36%
Dollar volume (20D)
375.16 K
ADR%
17.50
Earnings report date
Aug 28, 2024
Shares float
10.53 M
Shares short
14.00 K [0.13%]
Shares outstanding
19.78 M
Market cap
3.84 M
Beta
100.45
Price/earnings
N/A
20D range
0.13 0.33
50D range
0.13 0.54
200D range
0.13 2.93

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.

Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials.

The company is based in Tortola, British Virgin Islands.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Jun 6, 24 0.00
Increased by +100.00%
-0.22
Increased by +100.00%
Feb 28, 24 0.01
Increased by +102.27%
-0.27
Increased by +103.70%
Nov 28, 23 -0.29
Decreased by -383.33%
-0.28
Decreased by -3.57%
Aug 30, 23 -0.33
Decreased by -153.85%
-0.24
Decreased by -37.50%
May 31, 23 -5.36
Decreased by -857.14%
-0.29
Decreased by -1.75 K%
Mar 1, 23 -0.44
Decreased by -69.23%
-0.23
Decreased by -91.30%
Nov 29, 22 -0.06
Increased by +72.73%
-0.29
Increased by +79.31%
Aug 28, 22 -0.13
Increased by +48.00%
-0.30
Increased by +56.67%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 23 0.00
Decreased by N/A%
-39.37 M
Decreased by -424.90%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-5.16 M
Decreased by -375.39%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-94.45 M
Decreased by -965.64%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-94.45 M
Decreased by -965.64%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-7.50 M
Decreased by -113.58%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-1.08 M
Increased by +63.53%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by N/A%
-8.86 M
Increased by +22.92%
Decreased by N/A%
Decreased by N/A%
Mar 31, 22 0.00
Decreased by N/A%
-8.86 M
Increased by +22.92%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY